ES2168463T3 - Derivados fenilicos trisustituidos. - Google Patents
Derivados fenilicos trisustituidos.Info
- Publication number
- ES2168463T3 ES2168463T3 ES96908043T ES96908043T ES2168463T3 ES 2168463 T3 ES2168463 T3 ES 2168463T3 ES 96908043 T ES96908043 T ES 96908043T ES 96908043 T ES96908043 T ES 96908043T ES 2168463 T3 ES2168463 T3 ES 2168463T3
- Authority
- ES
- Spain
- Prior art keywords
- trisustituated
- phenylic
- derivatives
- phenylic derivatives
- substitutes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 208000000453 Skin Neoplasms Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000002062 proliferating effect Effects 0.000 abstract 1
- 201000000849 skin cancer Diseases 0.000 abstract 1
- 208000017520 skin disease Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C233/53—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
- C07C233/54—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/52—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
- C07C229/54—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C229/56—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring with amino and carboxyl groups bound in ortho-position
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/52—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
- C07C229/54—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C229/64—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring the carbon skeleton being further substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
- C07C271/28—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/74—Quinazolines; Hydrogenated quinazolines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to ring carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/94—Nitrogen atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Photoreceptors In Electrophotography (AREA)
Abstract
LA INVENCION TRATA DE COMPUESTOS DE FORMULA (I), EN LA CUAL LOS SUSTITUYENTES POSEEN DIVERSOS SIGNIFICADOS, Y DE SU UTILIZACION EN LA PREVENCION O EL TRATAMIENTO DE ENFERMEDADES DE PIEL INFLAMATORIAS O PROLIFERATIVAS Y CANCER.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9505080.3A GB9505080D0 (en) | 1995-03-14 | 1995-03-14 | Organic compounds |
GBGB9505858.2A GB9505858D0 (en) | 1995-03-23 | 1995-03-23 | Organic Compounds |
GBGB9526593.0A GB9526593D0 (en) | 1995-12-28 | 1995-12-28 | Organic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2168463T3 true ES2168463T3 (es) | 2002-06-16 |
Family
ID=27267624
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES96908043T Expired - Lifetime ES2168463T3 (es) | 1995-03-14 | 1996-03-14 | Derivados fenilicos trisustituidos. |
Country Status (24)
Country | Link |
---|---|
US (1) | US5990116A (es) |
EP (1) | EP0815087B1 (es) |
JP (1) | JP3194963B2 (es) |
KR (1) | KR100437580B1 (es) |
CN (1) | CN1101386C (es) |
AT (1) | ATE208763T1 (es) |
AU (1) | AU704544B2 (es) |
BR (1) | BR9607240A (es) |
CA (1) | CA2214131C (es) |
CZ (1) | CZ289944B6 (es) |
DE (1) | DE69616993T2 (es) |
DK (1) | DK0815087T3 (es) |
ES (1) | ES2168463T3 (es) |
FI (1) | FI120537B (es) |
HK (1) | HK1014440A1 (es) |
HU (1) | HUP9801828A3 (es) |
MX (1) | MX9707022A (es) |
NO (1) | NO310356B1 (es) |
NZ (1) | NZ304291A (es) |
PL (1) | PL185875B1 (es) |
PT (1) | PT815087E (es) |
RU (1) | RU2164224C2 (es) |
SK (1) | SK282155B6 (es) |
WO (1) | WO1996028430A1 (es) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5747498A (en) | 1996-05-28 | 1998-05-05 | Pfizer Inc. | Alkynyl and azido-substituted 4-anilinoquinazolines |
US6706721B1 (en) | 1998-04-29 | 2004-03-16 | Osi Pharmaceuticals, Inc. | N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrate |
JP3270834B2 (ja) | 1999-01-27 | 2002-04-02 | ファイザー・プロダクツ・インク | 抗がん剤として有用なヘテロ芳香族二環式誘導体 |
UA71945C2 (en) * | 1999-01-27 | 2005-01-17 | Pfizer Prod Inc | Substituted bicyclic derivatives being used as anticancer agents |
US7087613B2 (en) | 1999-11-11 | 2006-08-08 | Osi Pharmaceuticals, Inc. | Treating abnormal cell growth with a stable polymorph of N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride |
UA74803C2 (uk) | 1999-11-11 | 2006-02-15 | Осі Фармасьютікалз, Інк. | Стійкий поліморф гідрохлориду n-(3-етинілфеніл)-6,7-біс(2-метоксіетокси)-4-хіназолінаміну, спосіб його одержання (варіанти) та фармацевтичне застосування |
KR100819716B1 (ko) * | 2000-04-07 | 2008-04-07 | 칫소가부시키가이샤 | 신규한 디아미노 화합물, 당해 디아미노 화합물을사용하여 합성된 중합체, 및 당해 중합체를 사용하는니스, 배향막 및 액정 표시소자 |
CA2462442A1 (en) * | 2001-10-12 | 2003-04-24 | Warner-Lambert Company Llc | Alkyne matrix metalloproteinase inhibitors |
WO2003043961A2 (en) * | 2001-11-19 | 2003-05-30 | Iconix Pharmaceuticals, Inc. | Modulators of rho c activity |
MXPA05000476A (es) * | 2002-07-17 | 2005-03-23 | Warner Lambert Co | Combinacion de un inhibidor alquino alosterico de metaloproteinasa-13 de matriz con celecoxib o valdecoxib. |
JP2006502991A (ja) * | 2002-07-17 | 2006-01-26 | ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー | マトリックスメタロプロテイナーゼ−13のアロステリックアルキン阻害剤とセレコキシブまたはバルデコキシブではないシクロオキシゲナーゼ−2の選択的阻害剤との組合せ物 |
WO2004014384A2 (en) * | 2002-08-13 | 2004-02-19 | Warner-Lambert Company Llc | Cyclic compounds containing zinc binding groups as matrix metalloproteinase inhibitors |
GB0319497D0 (en) * | 2003-08-19 | 2003-09-17 | Novartis Ag | Organic compounds |
SE0400234D0 (sv) | 2004-02-06 | 2004-02-06 | Active Biotech Ab | New compounds, methods for their preparation and use thereof |
EP1740047A2 (en) * | 2004-03-11 | 2007-01-10 | Kythera Biopharmaceuticals, Inc. | Compositions and methods for preventing and treating skin and hair conditions |
US20080031898A1 (en) * | 2004-03-26 | 2008-02-07 | David Nathaniel E | Compositions and methods to increase the effect of a neurotoxin treatment |
GB0412769D0 (en) * | 2004-06-08 | 2004-07-07 | Novartis Ag | Organic compounds |
EP1780202B1 (en) * | 2004-08-04 | 2013-02-27 | Meiji Seika Pharma Co., Ltd. | Quinoline derivative and insecticide containing same as active constituent |
WO2008044688A1 (fr) * | 2006-10-11 | 2008-04-17 | Daiichi Sankyo Company, Limited | Dérivé de l'urée |
DE602008006679D1 (de) * | 2007-02-06 | 2011-06-16 | Chelsea Therapeutics Inc | Neue verbindungen, verfahren zu deren herstellung und deren verwendung |
EP3762379A1 (en) | 2018-03-07 | 2021-01-13 | Bayer Aktiengesellschaft | Identification and use of erk5 inhibitors |
WO2021026672A1 (en) * | 2019-08-09 | 2021-02-18 | Novartis Ag | Heterocyclic wdr5 inhibitors as anti-cancer compounds |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5651423A (en) * | 1979-09-13 | 1981-05-09 | Wellcome Found | Antiviral agent |
CA1219587A (en) * | 1981-12-14 | 1987-03-24 | Norman P. Jensen | Hydroxybenzylaminobenzenes as anti-inflammatory agents |
NZ213986A (en) * | 1984-10-30 | 1989-07-27 | Usv Pharma Corp | Heterocyclic or aromatic compounds, and pharmaceutical compositions containing such |
WO1988003806A1 (en) * | 1986-11-19 | 1988-06-02 | Chemex Pharmaceuticals, Inc. | Pharmacologically active compositions of catecholic butanes with zinc |
KR890700023A (ko) * | 1986-11-19 | 1989-03-02 | 케맥스 파마슈우티칼스 인코포레이티드 | 리폭시게나제 저해제 |
US4851423A (en) * | 1986-12-10 | 1989-07-25 | Schering Corporation | Pharmaceutically active compounds |
US5272167A (en) * | 1986-12-10 | 1993-12-21 | Schering Corporation | Pharmaceutically active compounds |
KR920701167A (ko) * | 1989-07-07 | 1992-08-11 | 에릭 에스. 딕커 | 약제학적 활성 화합물 |
HUT60458A (en) * | 1991-02-01 | 1992-09-28 | Sandoz Ag | Process for producing benzyloxyphenyl derivatives and pharmaceutical compositions comprising same |
SG64322A1 (en) * | 1991-05-10 | 1999-04-27 | Rhone Poulenc Rorer Int | Bis mono and bicyclic aryl and heteroaryl compounds which inhibit egf and/or pdgf receptor tyrosine kinase |
US5480883A (en) * | 1991-05-10 | 1996-01-02 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase |
GB9121943D0 (en) * | 1991-10-16 | 1991-11-27 | Sandoz Ltd | Organic compounds,processes for their production and their use |
US5656643A (en) * | 1993-11-08 | 1997-08-12 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase |
-
1996
- 1996-03-14 BR BR9607240A patent/BR9607240A/pt not_active IP Right Cessation
- 1996-03-14 DE DE69616993T patent/DE69616993T2/de not_active Expired - Fee Related
- 1996-03-14 SK SK1245-97A patent/SK282155B6/sk not_active IP Right Cessation
- 1996-03-14 EP EP96908043A patent/EP0815087B1/en not_active Expired - Lifetime
- 1996-03-14 US US08/913,597 patent/US5990116A/en not_active Expired - Fee Related
- 1996-03-14 KR KR1019970706458A patent/KR100437580B1/ko not_active IP Right Cessation
- 1996-03-14 JP JP52729096A patent/JP3194963B2/ja not_active Expired - Fee Related
- 1996-03-14 PT PT96908043T patent/PT815087E/pt unknown
- 1996-03-14 AU AU51443/96A patent/AU704544B2/en not_active Ceased
- 1996-03-14 CA CA002214131A patent/CA2214131C/en not_active Expired - Fee Related
- 1996-03-14 AT AT96908043T patent/ATE208763T1/de not_active IP Right Cessation
- 1996-03-14 CZ CZ19972869A patent/CZ289944B6/cs not_active IP Right Cessation
- 1996-03-14 ES ES96908043T patent/ES2168463T3/es not_active Expired - Lifetime
- 1996-03-14 NZ NZ304291A patent/NZ304291A/xx not_active IP Right Cessation
- 1996-03-14 PL PL96322134A patent/PL185875B1/pl not_active IP Right Cessation
- 1996-03-14 CN CN96193716A patent/CN1101386C/zh not_active Expired - Fee Related
- 1996-03-14 HU HU9801828A patent/HUP9801828A3/hu unknown
- 1996-03-14 DK DK96908043T patent/DK0815087T3/da active
- 1996-03-14 RU RU97117169/04A patent/RU2164224C2/ru not_active IP Right Cessation
- 1996-03-14 WO PCT/EP1996/001116 patent/WO1996028430A1/en active IP Right Grant
-
1997
- 1997-08-21 FI FI973440A patent/FI120537B/fi not_active IP Right Cessation
- 1997-09-08 NO NO19974118A patent/NO310356B1/no not_active IP Right Cessation
- 1997-09-12 MX MX9707022A patent/MX9707022A/es not_active IP Right Cessation
-
1998
- 1998-12-03 HK HK98112775A patent/HK1014440A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2168463T3 (es) | Derivados fenilicos trisustituidos. | |
ES2191152T3 (es) | Terapia combinada para el tratamiento de psicosis. | |
YU21401A (sh) | Tetrahidropiridoetri | |
EA200000723A1 (ru) | Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола | |
TNSN05045A1 (en) | Indole or benzimidazole derivatives for modulating ikappab kinase | |
ES2184149T3 (es) | Paclitaxeles 6-tio sustituidos. | |
PT639577E (pt) | Eteres fosfono-oximetilicos ou metiltiometilicos de derivados do taxano como agentes anti-tumor | |
ATE400577T1 (de) | Anellierte dihydropyrane | |
ES2056180T3 (es) | Nuevos derivados de 2'-halometiliden, 2'-eteniliden y 2'-etinil citidina. | |
ATE386742T1 (de) | Imidazonaphthyridine | |
CU23088A3 (es) | Compuestos de tetra-hidropiridina. | |
ES2162110T3 (es) | Derivados de la quinolina antimalaria. | |
ATE267816T1 (de) | Tan-1057 derivate | |
ATE381568T1 (de) | Pyrano(2,3-c)imidazo(1,2-a)pyridin-derivate zur behandlung von gastrointestinalen erkrankungen | |
IT1289154B1 (it) | Derivati di isoflavone loro preparazione e loro impiego terapeutico | |
DK1551850T3 (da) | 2"-oxo-voruscharin og derivater deraf | |
RU95118900A (ru) | Противоопухолевое средство | |
ES2106858T3 (es) | Nuevos derivados de la citarabina, su procedimiento de preparacion y su uso contra enfermedades cancerosas. | |
PE61999A1 (es) | Compuestos de tetrahidropiridina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 815087 Country of ref document: ES |